IKZF3 rs12934066: What Your Genotype Means
The genetic marker rs12934066 is a single-nucleotide polymorphism located within the 17q21 chromosomal region, specifically near the IKZF3 gene. Large-scale genome-wide association studies have identified this variant as part of a complex immune-regulatory locus linked to early-life respiratory traits such as childhood asthma and wheezing disorders. However, because rs12934066 resides in a dense region of strong linkage disequilibrium, individual carrier status reflects statistical risk rather than a direct clinical diagnosis.
What each genotype means
Typical risk profile
This genotype represents the more common state at this position in many populations. Research indicates that this variant is located in a region of high linkage disequilibrium on chromosome 17q21, where multiple genetic markers are associated with immune regulation and asthma risk. Because this region is complex, this genotype's specific contribution to individual health is difficult to isolate from neighboring genetic factors.
Carried by a significant portion of the population, with the C allele being the major allele in many non-European ancestries.
Intermediate risk profile
Carrying one copy of the T allele places you in an intermediate category for this specific genetic marker. This variant is part of a complex genomic locus associated with childhood asthma and immune system regulation, though the exact functional impact of this specific SNP remains under investigation. As with all genetic associations, this is a statistical observation and not a diagnostic indicator of health outcomes.
This heterozygous genotype is common, reflecting the high minor allele frequency of approximately 0.35–0.45 observed in European populations.
Increased risk association
This genotype is associated with the minor allele at this locus, which has been statistically linked in some studies to altered immune regulation and increased susceptibility to childhood asthma. Because this variant resides in a region with high linkage disequilibrium, it is often studied alongside other genes like ORMDL3 and GSDMB. Please remember that genetic associations are probabilistic, not deterministic, and should be discussed with a healthcare provider in the context of your overall health history.
This genotype is found in a substantial minority of individuals, particularly within European populations where the T allele frequency is elevated.
Chromosomal Location and the 17q21 Architecture
The single-nucleotide polymorphism rs12934066 resides on chromosome 17 at band 17q21. This segment of the human genome is widely recognized in human genetics as one of the most prominent susceptibility regions for pediatric asthma and chronic immune-mediated disorders. The 17q21 core region contains a dense cluster of genes in high linkage disequilibrium, meaning variations across these neighboring genes tend to be inherited together as a shared haplotype block. In addition to IKZF3, this locus encompasses genes such as ORMDL3, GSDMB, GSDMA, and ZPBP2. Because these genes lie in close physical proximity and share regulatory elements, statistical associations at rs12934066 reflect complex regional gene expression patterns rather than an isolated, disruptive coding lesion within a single isolated transcript.
Biological Role of the IKZF3 Gene
The IKZF3 gene encodes the zinc-finger transcription factor Aiolos, an essential regulator within the Ikaros family of DNA-binding proteins. Aiolos is heavily expressed in hematopoietic tissues and plays a fundamental role in controlling the development, selection, and activation of lymphoid lineages, especially B cells and CD4-positive T lymphocytes. Through chromatin remodeling and transcriptional modulation, Aiolos governs plasma cell differentiation, long-term humoral immunity, and cytokine sensitivity. Experimental models demonstrate that perturbations in IKZF3 function alter immune tolerance, lymphocyte proliferation, and type 2 inflammation. In the context of respiratory genetics, regulatory variants in or around IKZF3 are thought to influence how circulating immune cells respond to early viral infections and environmental allergens.
Research Associations and Evidence Strength
Genetic epidemiologic studies have linked rs12934066 and its surrounding 17q21 haplotype to an increased statistical risk of childhood-onset asthma, recurrent wheezing illnesses, and related immune traits. Genome-wide association studies show that risk alleles at this locus frequently correlate with acute respiratory episodes triggered by human rhinovirus infections during early life. Nevertheless, cataloged clinical databases classify the evidence for rs12934066 as limited. The effect sizes identified in population cohorts are modest, and the extensive linkage disequilibrium across the 17q21 block makes it challenging to designate IKZF3 as the sole causal driver over neighboring genes such as ORMDL3 or GSDMB. Consequently, the variant represents an exploratory trait marker rather than a definitive causal mutation.
Population Frequency and Ancestral Distribution
The single-nucleotide polymorphism rs12934066 is a common variant across human populations. In European cohorts, the minor allele frequency typically falls between 35% and 45%, making both heterozygous and homozygous genotypes frequent across the general population. Similar to other polymorphisms situated within the 17q21 linkage block, allele distributions vary across major continental ancestry groups, including African, Asian, and Admixed American populations. Because common variants with frequencies greater than 1% to 5% are widely tolerated in healthy humans, carrying one or more risk alleles at rs12934066 is normal human variation rather than a rare genetic disease state.
Interpreting Results: What This Means for You
Understanding your genotype at rs12934066 provides insight into biological variation within immune pathways, but it cannot be used as a standalone diagnostic tool. Possessing a statistical risk allele does not mean an individual will develop asthma or an autoimmune condition, nor does carrying protective or neutral alleles guarantee immunity from respiratory disorders. Asthma and autoimmune diseases are polygenic and heavily influenced by non-genetic factors, such as viral exposures, passive smoke, indoor allergens, and overall lifestyle. Genetic findings from commercial or research panels should never replace formal clinical evaluations, spirometry testing, or professional medical care.
How common is this variant?
The rs12934066 variant is common in global populations, exhibiting a minor allele frequency roughly between 0.35 and 0.45 in European ancestries, with varying frequencies across other global reference populations.
Frequently asked questions
Does having rs12934066 mean I will get asthma?
No, having an associated allele at rs12934066 does not mean you will develop asthma. Asthma is a complex, multifactorial condition caused by interactions between many genetic variants and environmental factors, such as viral infections and air quality. The variant confers only a small statistical risk shift.
Can this genetic test replace an allergy or lung exam?
No, consumer or research genetic testing for rs12934066 cannot substitute for medical diagnostics. Clinical diagnosis of asthma or allergies relies on physical examinations, lung function measurements like spirometry, and clinical symptom histories evaluated by qualified healthcare professionals.
Why is the 17q21 region so important in immunology research?
The 17q21 region is a prominent locus repeatedly identified in genome-wide association studies for pediatric asthma and autoimmune traits. It contains multiple tightly linked immune-related genes, including IKZF3, ORMDL3, and GSDMB, which collectively participate in lymphocyte regulation and airway epithelial responses.
How does the IKZF3 gene affect my immune system?
IKZF3 codes for Aiolos, a transcription factor involved in B cell development and T cell differentiation. It helps orchestrate how immune cells mature and respond to foreign pathogens, playing a vital role in balancing normal protective immunity and inflammatory responses.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12934066?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29